Evome Medical Technologies Inc. (TSXV: EVMT) has shown stability in its stock performance, with no significant fluctuations this week.
Evome Medical Technologies Inc. has seen its stock price remain flat this week, closing at C$0.01. Despite the lack of major news, the company has made strides in its financial performance in recent quarters, which may be of interest to retail investors.
Evome Medical Technologies Inc.
EVMT.V
EVMT.V
Evome Medical Technologies Inc.
WealthAwesomeMarket cap
$413,523
52W high
$16.84
52W low
$0.01
1W change
+333900.00%
Beta
1.29
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EVMT's historical volatility
30-Day Vol
2351.6%
Annualized
90-Day Vol
1365.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$19.96
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$17.72 | C$0.01 – C$59198.92 |
| 60 trading days | C$18.81 | C$0.00 – C$1810290.36 |
| 90 trading days | C$19.96 | C$0.00 – C$25326604.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should note Evome's recent financial results, indicating a positive trend in Adjusted EBITDA, while keeping an eye on its ongoing debt restructuring efforts.
C$0.01 Last Close with Stable Performance
Evome Medical Technologies has maintained a consistent stock price of C$0.01, reflecting a stable performance over the past week.
Bull case
The company’s steady revenues and positive Adjusted EBITDA in recent quarters suggest it may have room for future growth and operational stability.
Bear case
However, Evome's negative profit margins and high debt levels could pose risks, especially if its financial performance doesn’t continue to improve.
Price Action Overview
This week, Evome Medical Technologies Inc. (EVMT.V) has experienced no change in its stock price, maintaining a close of C$0.01. The stability reflects a lack of significant market catalysts or news that might have influenced trading activity.
Company News and Developments
Despite no major announcements this week, Evome has been in the news recently for its positive financial results. In its Q3 2024 report, released on November 25, 2024, the company reported an Adjusted EBITDA of $424,000, showcasing stable revenues. This follows a similar positive report for Q2 2024, where it reported an Adjusted EBITDA of $421,000. Such results highlight a potential trend of financial stabilization for the company.
Technical Picture
From a technical standpoint, Evome Medical Technologies is currently trading at its 50-day and 200-day moving averages of C$0.01, indicating a flat trend in price relative to these averages. The stock has a beta of 1.31, suggesting it is more volatile than the overall market. The lack of significant trading volume this week compared to its average could indicate limited investor interest at this time.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
